Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
- PMID: 12909720
- PMCID: PMC187891
- DOI: 10.1073/pnas.1633803100
Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
Abstract
There are many sources of genetic diversity, ranging from programmed mutagenesis in antibody genes to random mutagenesis during species evolution or development of cancer. We propose that mutations in DNA sequence-specific transcription factors that _target response elements (REs) in many genes can also provide for rapid and broad phenotypic diversity, if the mutations lead to altered binding affinities at individual REs. To test this concept, we examined the in vivo transactivation capacity of wild-type human and murine p53 and 25 partial function mutants. The p53s were expressed in yeast from a rheostatable promoter, and the transactivation capacities toward >15 promoter REs upstream of a reporter gene were measured. Surprisingly, there was wide variation in transactivation by the mutant p53s toward the various REs. This is the first study to address directly the impact of mutations in a sequence-specific transcription factor on transactivation from a wide array of REs. We propose a master gene hypothesis for phenotypic diversity where the master gene is a single transcriptional activator (or repressor) that regulates many genes through different REs. Mutations of the master gene can lead to a variety of simultaneous changes in both the selection of _targets and the extent of transcriptional modulation at the individual _targets, resulting in a vast number of potential phenotypes that can be created with minimal mutational changes without altering existing protein-protein interactions.
Figures
Similar articles
-
Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457. Oncogene. 2001. PMID: 11423991
-
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter _target sequence.Mol Cell Biol. 2002 Dec;22(24):8612-25. doi: 10.1128/MCB.22.24.8612-8625.2002. Mol Cell Biol. 2002. PMID: 12446780 Free PMC article.
-
Noncanonical DNA motifs as transactivation _targets by wild type and mutant p53.PLoS Genet. 2008 Jun 27;4(6):e1000104. doi: 10.1371/journal.pgen.1000104. PLoS Genet. 2008. PMID: 18714371 Free PMC article.
-
Potentiating the p53 network.Discov Med. 2010 Jul;10(50):94-100. Discov Med. 2010. PMID: 20670604 Review.
-
Functional diversity in the gene network controlled by the master regulator p53 in humans.Cell Cycle. 2005 Aug;4(8):1026-9. doi: 10.4161/cc.4.8.1904. Epub 2005 Aug 7. Cell Cycle. 2005. PMID: 16082206 Review.
Cited by
-
Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells.Onco_target. 2016 Sep 20;7(38):61630-61642. doi: 10.18632/onco_target.11210. Onco_target. 2016. PMID: 27533082 Free PMC article.
-
Whole-genome cartography of p53 response elements ranked on transactivation potential.BMC Genomics. 2015 Jun 17;16(1):464. doi: 10.1186/s12864-015-1643-9. BMC Genomics. 2015. PMID: 26081755 Free PMC article.
-
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system.PLoS One. 2011;6(6):e20643. doi: 10.1371/journal.pone.0020643. Epub 2011 Jun 2. PLoS One. 2011. PMID: 21674059 Free PMC article.
-
Parallel analysis of tetramerization domain mutants of the human p53 protein using PCR colonies.Genomic Med. 2007;1(3-4):113-24. doi: 10.1007/s11568-007-9011-8. Epub 2007 Sep 5. Genomic Med. 2007. PMID: 18923936 Free PMC article.
-
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its _target genes.Mol Cell Biol. 2006 Mar;26(6):2297-308. doi: 10.1128/MCB.26.6.2297-2308.2006. Mol Cell Biol. 2006. PMID: 16508005 Free PMC article.
References
-
- Gearhart, P. J. (2002) Nature 419, 29–31. - PubMed
-
- Hanahan, D. & Weinberg, R. A. (2000) Cell 100, 57–70. - PubMed
-
- Lucht, J. M., Mauch-Mani, B., Steiner, H. Y., Metraux, J. P., Ryals, J. & Hohn, B. (2002) Nat. Genet. 30, 311–314. - PubMed
-
- Giraud, A., Radman, M., Matic, I. & Taddei, F. (2001) Curr. Opin. Microbiol. 4, 582–585. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous